The influence of maternal antibodies on neonatal intestinal immunity
母源抗体对新生儿肠道免疫的影响
基本信息
- 批准号:9677877
- 负责人:
- 金额:$ 38.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-24 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAdultAntibodiesAntibody FormationAntibody ResponseAntigensB-Cell ActivationBacteriaBody WeightCharacteristicsComplement ActivationDefectDigestionDiseaseFc ReceptorGnotobioticGoalsHealthHelper-Inducer T-LymphocyteHomeostasisHumanHuman MilkIgG3ImmuneImmune responseImmune systemImmunityImmunoglobulin GImmunologyInflammatoryInflammatory ResponseIntestinesIntuitionLifeMammalsMaternal antibodyMicrobeMorbidity - disease rateMothersMucosal Immune ResponsesMucous MembraneMusNeonatalNewborn InfantNutrientPathogenicityPhysiologyPlayRoleSystemic infectionT cell responseT-LymphocyteTissuesWorkcolonization resistancecommensal bacteriadysbiosisenteric pathogengut bacteriahuman diseaseimmune functionimprovedin uterointestinal homeostasismembermicrobialmicrobiotamicroorganismmicroorganism antigenmortalitymouse modelneonatal immune systemneonatal immunityneonateoffspringpupreceptor functionresponse
项目摘要
How the neonatal immune system avoids inflammatory responses during initial acquisition of the microbiota
remains unclear. Establishing intestinal homeostasis is particularly challenging for neonates because their
immune systems have not fully developed. The goal of this application is to investigate how maternal
antibodies instruct the neonatal immune system to limit T cell responses to newly acquired microbial antigens
in the intestine. This proposal builds on our discovery that mothers generate T cell-independent IgG2b and
IgG3 antibodies reactive with the microbiota and pass these antibodies to their offspring in utero and through
breastmilk. Newborn mice that do not receive any maternal antibodies show increased translocation of
commensal bacteria across the intestinal barrier, mount inappropriate T cell responses against mucosal
antigens, and weigh less for the first few weeks of life. Similar defects are apparent in neonates that only lack
maternal IgG2b and IgG3, demonstrating that these isotypes are required to maintain intestinal homeostasis
early in life. Remarkably, if neonates are experimentally forced to acquire T-dependent IgG2c antibodies
reactive with the microbiota, then they suffer significant mortality and morbidity. Thus, our preliminary results
indicate that the type of antibody acquired by neonates from their mothers can dramatically impact health
during the first weeks of life. This proposal will determine the mechanism by which different IgG isotypes
suppress or enhance responses to the microbiota in neonates. In addition, we will determine whether specific
bacteria drive the immune dysregulation observed in the absence of maternal IgG antibodies or when
inflammatory IgG isotypes are acquired. Overall, the studies described in this proposal will reveal how
microbiota-reactive maternal antibodies regulate neonatal immunity to the microbiota.
新生儿免疫系统如何避免在菌群初次获得期间炎症反应
仍然不清楚。建立肠道稳态对新生儿特别具有挑战性
免疫系统尚未完全发展。该应用的目的是研究母亲
抗体指示新生儿免疫系统限制T细胞对新获得的微生物抗原的反应
在肠道中。这项建议是基于我们发现母亲产生与T细胞无关的IgG2B和
IgG3抗体用菌群反应,并将这些抗体传递给子宫内的后代,并通过
母乳。未接受任何母体抗体的新生小鼠显示出增加的易位
横跨肠屏障的共生细菌,对粘膜的不适当T细胞反应
抗原,生命的头几周重量减少。在仅缺乏的新生儿中,类似的缺陷也很明显
母体IgG2B和IgG3,证明这些同型需要维持肠内稳态
生命的早期。值得注意的是,如果新生儿被强迫获得T依赖性IgG2C抗体
用微生物群反应,然后遭受显着的死亡率和发病率。因此,我们的初步结果
表明新生儿从母亲那里获得的抗体类型会极大地影响健康
在生命的头几周。该建议将确定不同IgG同种型的机制
抑制或增强对新生儿微生物群的反应。此外,我们将确定是否具体
细菌驱动在没有母体IgG抗体或何时观察到的免疫失调
获得炎症性IgG同种型。总体而言,本提案中描述的研究将揭示如何
微生物群反应性母体抗体调节对微生物群的新生儿免疫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory M Barton其他文献
Gregory M Barton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory M Barton', 18)}}的其他基金
The Signal Transduction in the Immune System Conference
免疫系统会议中的信号转导
- 批准号:
10683527 - 财政年份:2023
- 资助金额:
$ 38.18万 - 项目类别:
Control of Regulatory T Cell Function by Toll-Like Receptor 7
Toll 样受体 7 对调节性 T 细胞功能的控制
- 批准号:
10438923 - 财政年份:2021
- 资助金额:
$ 38.18万 - 项目类别:
Control of Regulatory T Cell Function by Toll-Like Receptor 7
Toll 样受体 7 对调节性 T 细胞功能的控制
- 批准号:
10650735 - 财政年份:2021
- 资助金额:
$ 38.18万 - 项目类别:
Control of Regulatory T Cell Function by Toll-Like Receptor 7
Toll 样受体 7 对调节性 T 细胞功能的控制
- 批准号:
10304769 - 财政年份:2021
- 资助金额:
$ 38.18万 - 项目类别:
The influence of maternal antibodies on neonatal intestinal immunity
母源抗体对新生儿肠道免疫的影响
- 批准号:
9790941 - 财政年份:2018
- 资助金额:
$ 38.18万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Paid Sick Leave Mandates and Mental Healthcare Service Use
带薪病假规定和心理保健服务的使用
- 批准号:
10635492 - 财政年份:2023
- 资助金额:
$ 38.18万 - 项目类别:
Share plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with T1D and Their Care Partners
分享加:患有 T1D 的老年人及其护理伙伴的持续血糖监测和数据共享
- 批准号:
10660793 - 财政年份:2023
- 资助金额:
$ 38.18万 - 项目类别:
The impact of Medicaid expansion on the rural mortality penalty in the United States
医疗补助扩大对美国农村死亡率的影响
- 批准号:
10726695 - 财政年份:2023
- 资助金额:
$ 38.18万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 38.18万 - 项目类别: